(05-04-2020, 02:07 PM)crimsonghost747 Wrote:

(05-04-2020, 11:17 AM)Otter Wrote: New positions in AXP, BCE, and BMY

BCE is an interesting  add.
I've owned BCE for several years, and honestly it's such a boring stock that sometimes I forget that I even own it. Nothing happens. Ever. Even the quarterly reports are things that I scroll through in 5-10 minutes because there is nothing interesting in them. I don't think I've even read a single Seeking Alpha article about them in the past year. I'm not even sure if the CEO goes to work. You can hear the analysts snoring during the conference call. 

Okay those last two might be SLIGHT exaggerations. But only very slight. 
It is downright the most boring stock I have ever owned, which is not necessarily a bad thing these days.

(05-04-2020, 12:36 PM)divmenow Wrote:

(05-04-2020, 11:29 AM)fenders53 Wrote: Added ADM-IP-D-UPS

Just some 10-20 share pickups from my long list of limit orders.  I think most of them are going lower actually.

Also sold some puts, MO-KO-T-XEL so far.

I like UPS and D adds.... but ADM and IP.. Ewww 

No growth in either of those names. You mine as well have just put your money in PFE lol

(05-04-2020, 12:51 PM)fenders53 Wrote:

(05-04-2020, 12:31 PM)Otter Wrote:

(05-04-2020, 12:25 PM)fenders53 Wrote: Added some BMY shares and sold a put so I can be overweight if they blow earnings tomorrow.    

Seriously though, IMO it is probably the only big pharma stock that might be undervalued. We never know for sure until the drug trial results come in.  They have an important trial result coming in the next few weeks. It's rarely better than a 50/50 shot.  Their pipeline is as good as the competition.

GILD, MRK, and PFE also appear fairly valued. Not screaming deals, but fair value.

The only two stocks I have held 25+ years consecutive are PFE and XEL.  Guess which one isn't a 10 bagger?  I am wearing my "Pfizer Broken Dreams" T-shirt as I type this, so go tell your PFE lies somewhere else.     

I own over 500 shares of PFE.  Apparently I am a little slow lol.  I am overweight MRK.  I'd like to trim it but this is not the week.

(05-04-2020, 02:38 PM)Otter Wrote:

(05-04-2020, 12:36 PM)divmenow Wrote:

(05-04-2020, 11:29 AM)fenders53 Wrote: Added ADM-IP-D-UPS

Just some 10-20 share pickups from my long list of limit orders.  I think most of them are going lower actually.

Also sold some puts, MO-KO-T-XEL so far.

I like UPS and D adds.... but ADM and IP.. Ewww 

No growth in either of those names. You mine as well have just put your money in PFE lol

At least ADM is an aristocrat. They are kind of like NUE. They somehow manage to raise the payout annually for decades on end, in a volatile commodity-based industry that has bankrupted more players than not. I like it with a 4%+ yield, but certainly don't expect it to be the growthiest holding in my portfolio.

(05-04-2020, 02:46 PM)Otter Wrote: PFE has grown earnings by an average of 4.85% annually over the past 20 years (as far as I can go back in FAST Graphs). 20 years ago, PFE traded at $45.15 with a P/E north of 43. Today it trades at $37.71, but with a P/E of around 13.2. If PFE had traded at a rational earnings multiple of 15 or less 20 years ago, investors would have enjoyed positive total return over the intervening 20 years (although not market-beating). 

The chart for PFE (and a lot of other bubble stocks from the late 90s) is a helpful reminder any time I am tempted to buy DG, MSFT, WMT, and many others I would like to own, at present valuations.

(05-04-2020, 02:46 PM)Otter Wrote:

(05-04-2020, 12:51 PM)fenders53 Wrote:

(05-04-2020, 12:31 PM)Otter Wrote:

(05-04-2020, 12:25 PM)fenders53 Wrote: Added some BMY shares and sold a put so I can be overweight if they blow earnings tomorrow.    

Seriously though, IMO it is probably the only big pharma stock that might be undervalued. We never know for sure until the drug trial results come in.  They have an important trial result coming in the next few weeks. It's rarely better than a 50/50 shot.  Their pipeline is as good as the competition.

GILD, MRK, and PFE also appear fairly valued. Not screaming deals, but fair value.

The only two stocks I have held 25+ years consecutive are PFE and XEL.  Guess which one isn't a 10 bagger?  I am wearing my "Pfizer Broken Dreams" T-shirt as I type this, so go tell your PFE lies somewhere else.     

I own over 500 shares of PFE.  Apparently I am a little slow lol.  I am overweight MRK.  I'd like to trim it but this is not the week.

PFE has grown earnings by an average of 4.85% annually over the past 20 years (as far as I can go back in FAST Graphs). 20 years ago, PFE traded at $45.15 with a P/E north of 43. Today it trades at $37.71, but with a P/E of around 13.2. If PFE had traded at a rational earnings multiple of 15 or less 20 years ago, investors would have enjoyed positive total return over the intervening 20 years (although not market-beating). 

The chart for PFE (and a lot of other bubble stocks from the late 90s) is a helpful reminder any time I am tempted to buy DG, MSFT, WMT, and many others I would like to own, at present valuations.

(05-04-2020, 02:53 PM)EricL Wrote:

(05-04-2020, 02:46 PM)Otter Wrote: PFE has grown earnings by an average of 4.85% annually over the past 20 years (as far as I can go back in FAST Graphs). 20 years ago, PFE traded at $45.15 with a P/E north of 43. Today it trades at $37.71, but with a P/E of around 13.2. If PFE had traded at a rational earnings multiple of 15 or less 20 years ago, investors would have enjoyed positive total return over the intervening 20 years (although not market-beating). 

The chart for PFE (and a lot of other bubble stocks from the late 90s) is a helpful reminder any time I am tempted to buy DG, MSFT, WMT, and many others I would like to own, at present valuations.

I get what you are saying completely, but not sure why DG is named there. It's growing EPS at a double-digit rate and has a PE of 23 on FY21 estimates of $7.52 in earnings. It's expensive, but not outrageously so considering its growth rate.

(05-04-2020, 02:53 PM)EricL Wrote:

(05-04-2020, 02:46 PM)Otter Wrote: PFE has grown earnings by an average of 4.85% annually over the past 20 years (as far as I can go back in FAST Graphs). 20 years ago, PFE traded at $45.15 with a P/E north of 43. Today it trades at $37.71, but with a P/E of around 13.2. If PFE had traded at a rational earnings multiple of 15 or less 20 years ago, investors would have enjoyed positive total return over the intervening 20 years (although not market-beating). 

The chart for PFE (and a lot of other bubble stocks from the late 90s) is a helpful reminder any time I am tempted to buy DG, MSFT, WMT, and many others I would like to own, at present valuations.

I get what you are saying completely, but not sure why DG is named there. It's growing EPS at a double-digit rate and has a PE of 23 on FY21 estimates of $7.52 in earnings. It's expensive, but not outrageously so considering its growth rate.

(05-04-2020, 03:14 PM)fenders53 Wrote: Hindsight is always fun to second guess.  It looks clearly overvalued now but if you sold it early 2018 when it was overvalued you just missed a double. Nobody said this was easy.